• VETERINARY DIAGNOSTICS
    Visit MiraVistaVets.com for our Veterinary Test Menu, Order Forms and reference material
    MiraVistaVets.com
  • 100,000+ Tests Processed a Year
    MiraVista Diagnostics processes over 100,000 diagnostic tests for blastomyces, histoplasma, cryptococcus, aspergillus, coccidioides + beta-D glucan
    Learn More »
  • Fungal Infection Focus Since 2002
    MiraVista Diagnostics was founded and is lead by renowned infectious disease scientist Lawrence Joseph Wheat, MD
    Learn More »
  • CAP + CLIA Certified Lab
    MiraVista Diagnostics is a CLIA + CAP certified reference laboratory with an exclusive focus on diagnostic fungal testing
    Learn More »
  • Mycology Leader Since 2002
    MiraVista Diagnostics was founded and is lead by renowned infectious disease scientist Lawrence Joseph Wheat, MD
    Learn More »
  • 1,000+ Scientific Research Papers
    MiraVista Diagnostic has over 1,000 scientific research papers published in leading infectious disease + clinical laboratory journals
    Learn More »
  • 20+ Years Of Diagnostic Testing
    MiraVista collaborates with clinicians, researchers, and clinical laboratories to develop valuable diagnostic solutions.
    Learn More »
  • Fungal Infection Expert Since 2002
    MiraVista Diagnostics develops and processes diagnostics tests for blastomyces, histoplasma, cryptoccus, aspergillus, coccidioides + beta-D glucan
    Learn More »
  • We're Hiring!
    Join a team of enthusiastic professionals at an innovative + growing life science organization
    Apply Today »
Announcements

MiraVista Institutional Biosafety Committee (IBC) Announcement

In compliance with NIAID/NIH guidelines research at MiraVista Diagnostics utilizing synthetic or recombinant DNA is annually reviewed by the MiraVista Institutional Biosafety Committee (IBC). The IBC is made up of internal and external subject matter experts to ensure that MiraVista…
READ MORE →

Pulmonary Histoplasmosis: A Clinical Update – Published

MiraVista Diagnostics’ article “Pulmonary Histoplasmosis: A Clinical Update” has been published in “Journal of Fungi” as part of the Special Issue “Diagnosis and Treatment of Invasive Pulmonary Fungal Infections.” Read the article. View the PDF.    

Diagnosis of Histoplasmosis Using the MVista Histoplasma Galactomannan Antigen Qualitative Lateral Flow–Based Immunoassay: A Multicenter Study.

The second US based multicenter study found high concordance with the MiraVista LFA and EIA and reported higher sensitivity with the EIA. Read more about the US LFA Multicenter Study.  

Validation and Concordance Analysis of a New Lateral Flow Assay for Detection of Histoplasma Antigen in Urine

Several studies have recently been published, evaluated the MVista® CE marked Histoplasma urine antigen lateral flow immunoassay. The first study was conducted in Columbia in partnership with the CDC and reported high sensitivity with the MVD LFA. Read more about…
READ MORE →

MiraVista Institutional Biosafety Committee (IBC) Announcement

In compliance with NIAID/NIH guidelines research at MiraVista Diagnostics utilizing synthetic or recombinant DNA is annually reviewed by the MiraVista Institutional Biosafety Committee (IBC). The IBC is made up of internal and external subject matter experts to ensure that MiraVista…
READ MORE →

Test Report Updates for 2021

In order to maintain good business practices, MiraVista Diagnostics is providing a 90-day notice of pending updates to our referral testing customers. Beginning March 1, 2021 MiraVista Diagnostics will transition to an improved MVista® Histoplasma Antigen Quantitative EIA. The new…
READ MORE →

Are You Underdiagnosing Coccidioidomycosis?

Are You Underdiagnosing Coccidioidomycosis? Capture Additional Cases with Combined Antigen and Antibody Testing. Dear Colleagues, The prevailing method for diagnosis of coccidioidomycosis is serum antibody testing by immunodiffusion (ID) with a sensitivity of 84.2% and specificity of 96.5%, but a…
READ MORE →

Experience the Advantage

Chemist at work

MiraVista Diagnostics is the Authority on Serious Fungal Infections

Since MiraVista Diagnostics was founded in 2002 by the renowned infectious disease scientist, Lawrence Joseph Wheat, MD, the company has been the leading authority on serious fungal infections. Today, MiraVista is a CAP + CLIA certified clinical laboratory that processes over 100,000 fungal diagnostic tests every year. MiraVista is respected for its scientific contributions and selected for its:
  • Menu of Fungal Infection Tests
  • Onsite Clinical Reference Lab
  • Same Day Testing
  • Prompt + Professional Response
  • Fast Turnaround Time
  • Experienced ID Specialists

Let us earn your trust and your business. Order fungal diagnostic tests today to experience the MiraVista advantage.

  • vendor logo
  • vendor logo
  • vendor logo
  • vendor logo
  • vendor logo